Filing Flows › Invo Fertility (IVF) › Q2 2026
Invo Fertility (IVF) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Invo Fertility (IVF) reported revenue of $2.2M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +8% from the quarter before. Operating margin was -59.3%, net earnings $889K (40.9% of revenue).
Invo Fertility, Q2 2026: revenue $2.2M (+17% year over year), operating margin -59.3%, net earnings $889K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | +8% | +17% |
| Operating profit | −$1.3M | — | — |
| Net earnings | $889K | — | — |
| Operating cash flow | −$1.1M | — | — |
What changed
Revenue was $2.2M in Q2 2026, up 17% year over year and up 8% from the previous quarter. Clinic Revenue was the largest line at 100% of revenue. Clinic Revenue added $336K year over year (up 18%), 108% of the total change. Product declined 76%.
Operating costs exceeded revenue by $1.3M, an operating margin of -59.3%. Total costs fell 29% while revenue rose 17%. The fastest-growing cost line was Cost of revenue (+1864%). Net earnings were $889K. The effective tax rate was 5.9%. Non-operating items added $2.2M, 236% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.1M. Non-cash charges added back $146K of depreciation and amortization. Working capital and other items used $2.1M.
Questions
What was Invo Fertility's revenue in the second quarter 2026?
Invo Fertility (IVF) reported revenue of $2.2M for the second quarter 2026 (Q2 2026), +17% from a year earlier and +8% from the quarter before.
Was Invo Fertility profitable in the second quarter 2026?
Operating loss was $1.3M (-59.3% of revenue) and net earnings $889K.
Source: Invo Fertility 10-Q on SEC EDGAR.